Related Experiment Videos
Smoking cessation. Techniques and benefits.
G A Lillington1, C T Leonard, D P Sachs
1Palo Alto Center for Pulmonary Disease Prevention, California, USA.
Clinics in Chest Medicine
|April 14, 2000
Summary
Tobacco dependency is a disease often requiring medication alongside behavioral therapy. Effective treatments include bupropion and various nicotine replacement therapies, sometimes used together for better results.
Area of Science:
- Addiction Medicine
- Neuroscience
- Pharmacology
Background:
- Tobacco dependency syndrome is an organic disease stemming from chronic inhaled tobacco smoke exposure.
- While willpower can be a factor, managing psychological aspects often necessitates pharmacotherapy.
- This highlights the complex nature of nicotine addiction and its treatment challenges.
Purpose of the Study:
- To outline effective pharmacotherapies for tobacco dependency syndrome.
- To discuss the role of both bupropion and nicotine replacement therapies (NRTs) in smoking cessation.
- To explore the potential for combined drug and NRT modality use.
Main Methods:
- Review of established pharmacotherapies for nicotine addiction.
- Examination of bupropion as an oral antidepressant adjunct.
- Analysis of various nicotine administration modalities (patch, inhalant, nasal spray, oral preparation).
Main Results:
- Bupropion and nicotine therapies are effective for tobacco dependence.
- Multiple nicotine modalities can be used concurrently with bupropion.
- High-dose nicotine therapy can yield high abstinence rates during treatment, but long-term maintenance is challenging.
Conclusions:
- Pharmacotherapy, including bupropion and NRTs, is crucial for managing tobacco dependency.
- Combined treatment strategies may enhance cessation success.
- Persistent brain changes from smoking may impede long-term, drug-free abstinence.